419
Views
60
CrossRef citations to date
0
Altmetric
Research Articles

Formulation of piperine solid lipid nanoparticles (SLN) for treatment of rheumatoid arthritis

, , &
Pages 1003-1010 | Received 11 Jul 2016, Accepted 31 Jan 2017, Published online: 01 Mar 2017

References

  • Sweeny SE, Fierestein GS. Rheumatoid arthritis: regulation of synovial inflammation. IJBCB 2004;36:372–8.
  • Singh P, Robert MS. Skin permeability and local tissue concentration of non-steroidal anti-inflammatory drugs after topical application. J Pharmcol Exp Ther 1994;268:144–51.
  • Kaur A, Nain P, Nain J. Herbal plant used in rheumatoid arthritis: a review. Int J Pharm Pharm Sci 2012;4:4.
  • Vasavirama K, Upender M. Piperine: a valuable alkaloid from piper species. Inter J Pharm Pharm Sci 2014;6:34–8.
  • Bang JS, Oh DH, Choi HM, et al. Anti inflammatory and antiarthritic effects of piperine in human interleukin 1β-stimulated fibroblast-like synoviocytes and in rat arthritis models. Arthritis Res Ther 2009;11:R49.
  • Bhalekar MR, Upadhaya PG, Nalawade SD, et al. Anti-rheumatic activity of chloroquine-SLN gel on Wistar rats using complete Freund’s adjuvant (CFA) model. Indian J Rheumatol 2015;10:58–64.
  • Bhalekar MR, Upadhaya PG, Madgulkar AR. Fabrication and efficacy evaluation of chloroquine nanoparticles in CFA-induced arthritic rats using TNF-α ELISA. EJPS 2016;84:1–8.
  • Sacchetti M, Nejati E. Prediction of drug solubility in lipid mixtures from the individual ingredients. AAPS PharmSciTech 2012;13:1103–9.
  • Li S, Ji Z, Zou M. Preparation, characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrine. AAPS PharmSciTech 2011;12:1011–8.
  • Gambhire M, Bhalekar M, Shrivastava B. Bioavailability assessment of simvastatin loaded solid lipid nanoparticles after oral administration. As J of Pharm Sci 2011;6:251–8.
  • Padamwar MN, Pokharkar VB. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability. Int J Pharm 2006;320:37–44.
  • Bhalekar MR, Pokharkar V, Madgulkar A. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. AAPS PharmSciTech 2009;10:289–96.
  • Vennishetty VK, Komuravekki R, Kuncha M, et al. Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticles. Nanomedicine 2013;9:111–21.
  • Das MK, Ahmed AB. Formulation and evaluation of rofecoxib gel for topical application. Acta Pol Pharm 2007;63:461–7.
  • Carter SJ. Cooper and Gunn’s dispersion of pharmaceutical students. 12th edn. Delhi: CBS Publishers and Distributors; 2000. 192–9 p.
  • Mandawgade SD, Patravale VB. Development of SLNs from natural lipids: application to topical delivery of tretinoin. Int J Pharm 2008;363:132–8.
  • fda.gov[Internet]. Rockville, MD: Food and Drug Administration. [cited 2017 Feb 19]. Available from: http://www.fda.gov/cder/guidance/index.htm.
  • Todorovic Z, Medic B, Basta-Jovanovic G, et al. Acute pretreatment with chloroquine attenuates renal I/R. PloS One 2014;9:1–10.
  • Singh B, Bani S, Gupta DK, et al. Anti-inflammatory activity of ‘TAF’ an active fraction from the plant Barleria prionitis Linn. J Ethnopharmacol 2003;85:187–93.
  • Barton NJ, Stevens DA, Hughes JP, et al. Demonstration of a novel technique to quantitatively assess inflammatory mediators and cells in rat knee joints. J Inflamm 2007;4:13.
  • Zimmermann E, Souto EB, Müller RH. Physicochemical investigations on the structure of drug-free and drug-loaded solid lipid nanoparticles (SLN) by means of DSC and 1H NMR. Pharmazie 2005;60:508–13.
  • Mäder K, Mehnert W. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 2012;64:83–101.
  • Diembeck W, Beck H, Benech-kieffer F. Test guidelines for in vitro assessment of dermal absorption and percutaneous penetration of cosmetic ingredients. Food Chem Toxicol 1999;37:191–205.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.